BAILEY SIMON,BURKE BENJAMIN JOSEPH,COLLINS MICHAEL RAYMOND,CUI JINGRONG JEAN,DEAL JUDITH GAIL,HOFFMAN ROBERT LOUIS,HUANG QINHUA,JOHNSON TED WILLIAM,KANIA ROBERT STEVEN,KATH JOHN CHARLES,LE PHUONG THI,HOFFMAN ROBE
申请号：
PL13717555
公开号：
PL2822953T3
申请日:
2013.02.20
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
The invention relates to compounds of formula (&Phi；) as further defined herein and to the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to the uses thereof. The compounds and salts of the present invention inhibit anaplastic lymphoma kinase (ALK) and/or EML4-ALK and are useful for treating or ameliorating abnormal cell proliferative disorders, such as cancer.
